Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-08-16

Clinical Trial Update: Artemether-Lumefantrine Clinical Effectiveness Study [Phase 4]

View source ↗

Summary

Phase 4 clinical trial assessing the effectiveness of artemether-lumefantrine for malaria, sponsored by the Papua New Guinea Institute of Medical Research; the …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Artemether-lumefantrine (artemether and lumefantrine)

Snippet

Sponsor: Papua New Guinea Institute of Medical Research | Conditions: Parasitologically Confirmed; Malarial | Phase 4 | Status: COMPLETED